Health Sciences

PRA Health Sciences was a leading global contract research organization (CRO) providing a full range of clinical development services to the pharmaceutical and biotechnology industries. Headquartered in Raleigh, North Carolina, the company specialized in managing Phase I through Phase IV clinical trials across a broad spectrum of therapeutic areas, including oncology, immunology, and infectious diseases. PRA was known for its robust technology platforms and data-driven approach to clinical research, offering services such as clinical trial management, regulatory affairs, and pharmacovigilance. In July 2021, the company was acquired by ICON plc in a transaction valued at approximately $12 billion, creating one of the world's largest healthcare intelligence and clinical research organizations. Today, its operations are integrated into ICON, continuing to support global drug development through decentralized and hybrid trial solutions.